Aaron Sverdlov, Co-Director of the Newcastle Centre of Excellence in Cardio-Oncology at Hunter Medical Research Institute (HMRI), shared a post on LinkedIn:
“Honoured to have presented at Haematology Society of Australia and New Zealand Blood2025 Congress
My talk, as part of the “CLL – cut the CLUTTER!” session, focused on how we can reduce the “real-world clutter” that derails BTK therapy by tightening supportive care and proactively managing cardiovascular risk:
- Baseline CV risk assessment for all patients starting BTKi – CV toxicity risk is dynamic across the cancer journey.
- Anticipate and treat hypertension early: home BP monitoring/diaries plus proactive optimisation reduces downstream complications and avoids preventable treatment disruption.
- Have a clear AF pathway and assess stroke/bleeding risk.
CV complications are predictable and manageable when haematology and cardiology work together.”
More posts featuring Aaron Sverdlov on OncoDaily.